Stockscreener 앱 받기
4.88
8.69%
0.39
전일 마감가:
$4.49
열려 있는:
$4.62
하루 거래량:
59,012
Relative Volume:
1.32
시가총액:
$209.97M
수익:
$4.71M
순이익/손실:
$-46.77M
주가수익비율:
-2.9061
EPS:
-1.6792
순현금흐름:
$-60.34M
1주 성능:
+4.50%
1개월 성능:
-2.59%
6개월 성능:
-25.72%
1년 성능:
-53.44%
1일 변동 폭
$4.56
$4.95
1주일 범위
$4.1001
$4.95
52주 변동 폭
$4.1001
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
4.88 | 193.19M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
500.76 | 175.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
182.68 | 50.46B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
82.29 | 39.65B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
47.71 | 38.41B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
258.91 | 37.27B | 5.40B | 1.49B | 1.78B | 10.12 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-31 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2022-04-21 | 개시 | Oppenheimer | Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2021-12-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Nyxoah Sa 주식(NYXH)의 최신 뉴스
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - Bitget
Nyxoah Announces the Signature of a Memorandum of - GlobeNewswire
Nyxoah SA (NASDAQ:NYXH) Short Interest Up 29.0% in January - Defense World
(NYXH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Contrasting Hinge Health (NYSE:HNGE) and Nyxoah (NASDAQ:NYXH) - Defense World
Is Nyxoah SA stock undervalued right nowJuly 2025 Highlights & Weekly Stock Breakout Alerts - mfd.ru
Nyxoah SA (NYXH) Stock Analysis: A Healthcare Innovator with a Promising 138.98% Upside Potential - DirectorsTalk Interviews
Returns Recap: Will Nyxoah SA benefit from AI trendsWeekly Stock Recap & Community Supported Trade Ideas - baoquankhu1.vn
Is Nyxoah SA stock overvalued or fairly pricedJuly 2025 Update & Fast Gain Swing Trade Alerts - mfd.ru
Can Nyxoah SA expand into new marketsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - mfd.ru
What is the long term forecast for Nyxoah SA stockJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - mfd.ru
Nyxoah's Revenue On The Rise- Will The Stock Wake From Its Slumber? - RTTNews
Guidance Update: Is now the right time to enter Nyxoah SABond Market & Daily Stock Trend Watchlist - baoquankhu1.vn
Price-Driven Insight from (NYXH) for Rule-Based Strategy - Stock Traders Daily
Nyxoah SA (NYXH) Stock Analysis: A 137% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Aug PreEarnings: Can Nyxoah SA sustain its profitabilityBear Alert & Expert Approved Trade Ideas - baoquankhu1.vn
Price Action: Should I hold or sell Nyxoah SA now2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn
Ideas Watch: Is now the right time to enter Nyxoah SAQuarterly Trade Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Will Nyxoah SA benefit from rising consumer demandWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn
Nyxoah (NASDAQ:NYXH) Shares Down 0.4% – Time to Sell? - Defense World
Nyxoah (NASDAQ:NYXH) Shares Down 0.4%Time to Sell? - MarketBeat
Nyxoah Expands Belgian Manufacturing Hub to Support Global Growth in OSA Therapy - The Globe and Mail
Risk Hedge: Is Nyxoah SA stock a good dividend stockTrade Ideas & Long-Term Growth Plans - mfd.ru
Can Nyxoah SA sustain its profitabilityJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - mfd.ru
Volume Report: Can Nyxoah SA ride the EV waveQuarterly Portfolio Review & Weekly High Return Forecasts - baoquankhu1.vn
Nyxoah Expands Belgian Manufacturing Capacity to Support Global Growth - Sleep Review
Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Nyxoah invests in further expanding its Belgian manufacturing capacity to support its worldwide growth - marketscreener.com
Nyxoah says co invests expanding its Belgian manufacturing capacity - marketscreener.com
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewswire
Does Nyxoah SA have pricing power2025 Risk Factors & Growth Focused Stock Reports - bollywoodhelpline.com
Aug Sectors: Is Flanigans Enterprises Inc stock a falling knife or bargain buy2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn
(NYXH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NYXH: Rapid U.S. launch and strong clinical results position Genio for significant market growth - TradingView
NYXH: Genio's innovative sleep apnea device drives rapid U.S. adoption and strong early sales - TradingView — Track All Markets
Oppenheimer Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛
Nyxoah’s First Full U.S. Sales Quarter Fuels Triple-Digit Revenue Growth in 2025 - The Globe and Mail
Nyxoah (NASDAQ: NYXH) reports preliminary 2025 results and Q1 2026 view - Stock Titan
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target By Investing.com - Investing.com South Africa
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $12 - 富途资讯
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target - Investing.com Australia
Is Nyxoah SA stock a safe investment in uncertain markets2025 Growth vs Value & Verified Swing Trading Watchlist - Bộ Nội Vụ
Belgium-based Nyxoah’s net revenue expected to increase 348% in Q4 2025 - Medical Buyer
Nyxoah Shares Surge On Strong Q4 Preliminary Revenue - Nasdaq
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 - The Manila Times
News - FinancialContent
Publication relating to transparency notification - GlobeNewswire
Nyxoah SA's (EBR:NYXH) market cap rose €19m last week; retail investors who hold 44% profited and so did insiders - simplywall.st
Aug Opening: Is Nyxoah SA stock a contrarian buyJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - Bộ Nội Vụ
Is Nyxoah SA stock a good choice for value investorsSeasonal Picks & what to check before ordering - Улправда
Is Nyxoah SA stock a contrarian buyMarket Risk Summary & Free Fast Gain Swing Trade Alerts - Улправда
Nyxoah Sa (NYXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.60%
자본화:
|
볼륨(24시간):